{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:38:14Z","timestamp":1792679894821,"version":"4.5.0"},"reference-count":14,"publisher":"MyJove Corporation","issue":"119","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/55049","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T19:00:11Z","timestamp":1483642811000},"source":"Crossref","is-referenced-by-count":11,"title":["Cell-Free DNA Integrity Analysis in Urine Samples"],"prefix":"10.3791","author":[{"given":"Valentina","family":"Casadio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Salvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Martignano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gunelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ravaioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Calistri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"14122","DOI":"10.3390\/ijms160614122","type":"journal-article","article-title":"Circulating Cell-Free Tumour DNA in the Management of Cancer","volume":"16","author":"Francis","year":"2015","unstructured":"Francis, G., & Stein, S. Circulating Cell-Free Tumour DNA in the Management of Cancer. Int.J.Mol.Sci. 16 (6), 14122-14142 [doi] (2015).","journal-title":"Int.J.Mol.Sci"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32607\/20758251-2015-7-3-48-54","type":"journal-article","article-title":"Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential","volume":"7","author":"Bryzgunova","year":"2015","unstructured":"Bryzgunova, O.E., & Laktionov, P.P. Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential. Acta Naturae. 7 (3), 48-54 (2015).","journal-title":"Acta Naturae"},{"issue":"2","key":"ref3","first-page":"405","type":"journal-article","article-title":"Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment","volume":"18","author":"Szarvas","year":"2007","unstructured":"Szarvas, T., et al. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. Oncol.Rep. 18 (2),405-409 [doi] (2007).","journal-title":"Oncol.Rep"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2015.281","type":"journal-article","article-title":"Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA","author":"Togneri","year":"2016","unstructured":"Togneri, F.S., et al. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. Eur.J.Hum.Genet. [doi] (2016).","journal-title":"Eur.J.Hum.Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.acc.2015.03.002","type":"journal-article","article-title":"Assessment of DNA Integrity, Applications for Cancer Research","volume":"70","author":"Zonta","year":"2015","unstructured":"Zonta, E., Nizard, P., & Taly, V. Assessment of DNA Integrity, Applications for Cancer Research. Adv.Clin.Chem. 70, 197-246 [doi] (2015).","journal-title":"Adv.Clin.Chem"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bjc.2014.470","type":"journal-article","article-title":"Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer","volume":"111","author":"Hao","year":"2014","unstructured":"Hao, T.B., et al. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. Br.J.Cancer. 111 (8), 1482-1489 [doi] (2014).","journal-title":"Br.J.Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"574120","DOI":"10.1155\/2015\/574120","type":"journal-article","article-title":"Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients","volume":"2015","author":"Salvi","year":"2015","unstructured":"Salvi, S., et al. Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients. Dis.Markers. 2015, 574120 [doi] (2015).","journal-title":"Dis.Markers"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"270457","DOI":"10.1155\/2013\/270457","type":"journal-article","article-title":"Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study","volume":"2013","author":"Casadio","year":"2013","unstructured":"Casadio, V., et al. Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. Biomed.Res.Int. 2013, 270457 [doi] (2013).","journal-title":"Biomed.Res.Int"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.urolonc.2012.07.013","type":"journal-article","article-title":"Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data","volume":"31","author":"Casadio","year":"2013","unstructured":"Casadio, V., et al. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data. Urol.Oncol. 31 (8), 1744-1750 [doi] (2013).","journal-title":"Urol.Oncol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/bjc.2015.128","type":"journal-article","article-title":"Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone","volume":"112","author":"Salvi","year":"2015","unstructured":"Salvi, S., et al. Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.Br.J.Cancer. 112 (10), 1717-1724 [doi] (2015).","journal-title":"Br.J.Cancer"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/pros.20959","type":"journal-article","article-title":"High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer","volume":"69","author":"Ishkanian","year":"2009","unstructured":"Ishkanian, A.S., et al. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate. 69 (10), 1091-1100 [doi] (2009).","journal-title":"Prostate"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/jcp.55.2.118","type":"journal-article","article-title":"Her-2\/neu oncogene amplification in clinically localised prostate cancer","volume":"55","author":"Oxley","year":"2002","unstructured":"Oxley, J.D., Winkler, M.H., Gillatt, D.A., & Peat, D.S. Her-2\/neu oncogene amplification in clinically localised prostate cancer. J.Clin.Pathol. 55 (2), 118-120 (2002).","journal-title":"J.Clin.Patho"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/ijc.24954","type":"journal-article","article-title":"Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma","volume":"126","author":"Nord","year":"2010","unstructured":"Nord, H., et al. Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. Int.J.Cancer. 126 (6), 1390-1402 [doi] (2010).","journal-title":"Int.J.Cancer"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"e14632","DOI":"10.1371\/journal.pone.0014632","type":"journal-article","article-title":"Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer","volume":"6","author":"Tabach","year":"2011","unstructured":"Tabach, Y., et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS One. 6 (1), e14632 [doi] (2011).","journal-title":"PLoS One"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jove.com\/video\/55049\/cell-free-dna-integrity-analysis-in-urine-samples","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:44:41Z","timestamp":1792676681000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/55049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":14,"journal-issue":{"issue":"119","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3791\/55049","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]}}}